Brug af ropinirol mod Restless Legs Syndrome I kliniske undersøgelser vedrørende RLS var den mest almindelige bivirkning kvalme (cirka 30% af patienterne).
In Restless Legs Syndrome clinical trials the most common adverse drug reaction was nausea (approximately 30% of patients).